A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Carfilzomib Impurity 83 - Request Quote

Picture of Carfilzomib Impurity 83

Carfilzomib Impurity 83

SZ CAT No:SZ-C070098
CAS No
NA
Mol.F.
C41H61N5O10S
Mol.Wt.
816.0
Inv. Status
Synthesis on demand

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Carfilzomib Impurity 83 is chemically (4S,7S,10S,13S,15R)-10-benzyl-15-hydroxy-7,13-diisobutyl-15-methyl-2,5,8,11,14-pentaoxo-4-phenethyl-3,6,9,12-tetraazahexadecan-16-yl morpholinomethanesulfonate. Carfilzomib Impurity 83 is supplied with detailed characterization data compliant with regulatory guideline. Carfilzomib Impurity 83 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Carfilzomib.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

buy high quality Carfilzomib Impurity 83

Purchase Carfilzomib Impurity 83

Carfilzomib Impurity 83 suppliers

Carfilzomib Impurity 83 manufacturers

Carfilzomib Impurity 83 price

Order Carfilzomib Impurity 83

Enquire Carfilzomib Impurity 83

Carfilzomib Impurity 83 cost

Carfilzomib Impurity 83 Supplier

Carfilzomib Impurity 83 Distributor

Carfilzomib Impurity 83 for Method Validation

Carfilzomib Reference Standard

Carfilzomib Impurity 83 for ANDA Filing

Carfilzomib Impurity 83 for Forced Degradation Studies

Carfilzomib Impurity 83 Identification Standards

Carfilzomib Impurity 83 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,